Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer’s disease in patients with chronic hepatitis B virus infection
Our study analyses suggest that NUC therapy appears to have a protective effect against the development of AD in patients with CHB.
Authors
- Ji Hyae Lim (ORCID: https://orcid.org/0000-0002-1105-7235)
- Hyunji Sang (ORCID: https://orcid.org/0000-0003-2557-5911)
- Su Jin Jeong (ORCID: https://orcid.org/0000-0003-4025-4542)
- Ha Il Kim (ORCID: https://orcid.org/0000-0002-5471-7790)
- Hyundam Gu (ORCID: https://orcid.org/0000-0001-5898-4004)
Institutions
- Johns Hopkins University (US)
- Kyung Hee University Medical Center (KR)
Publication Details
- Journal
- Alzheimer s Research & Therapy
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1186/s13195-025-01729-3
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hanyang University
- Korean Association for the Study of the Liver